UPDATE: Vivos Therapeutics (VVOS) Could Change the Lives of 22M US Adults, Craig-Hallum Starts at Buy Ahead of Stanford Trial Data

Go back to UPDATE: Vivos Therapeutics (VVOS) Could Change the Lives of 22M US Adults, Craig-Hallum Starts at Buy Ahead of Stanford Trial Data
(NASDAQ: VVOS) Delayed: 0.34 +0.03 (9.68%)
Previous Close $0.31    52 Week High
Open $0.31    52 Week Low
Day High $0.36    P/E N/A 
Day Low $0.30    EPS
Volume 1,714,453